News & Events
New York, NY March 27, 2012
Guidepoint Global Aesthetics Market Tracker Achieves Five-Year Milestone
Guidepoint Global, LLC, a leading primary research firm serving Corporations, Institutional Investors and Consultancies, announced the five-year anniversary of its Aesthetics Market Tracker. The Aesthetics Market Tracker delivers monthly web-based access to business and competitive insight such as market share, market size and growth for US Breast Implants, Dermal Fillers and Neurotoxins.
We are very excited to have surpassed the five-year milestone with the Aesthetics data sets. Over the past few years the Aesthetics market has experienced significant challenges and events that have
"With the March 9th approval by the U.S. FDA of Sientra Inc’s Silimed silicone gel-filled breast implant, Guidepoint’s data will look to capture how this launch will affect overall volumes and manufacturer market shares going forward."
been illuminated in our data,” said Brian Cosgrove, Director of Guidepoint’s Tracker Team, and the Analyst who has led Guidepoint’s Aesthetics coverage since its launch in January 2007.
Guidepoint’s Aesthetics Suite includes Trackers for four distinct areas, aggregating monthly Breast Implant, Dermal Filler, Neurotoxin and Weight Loss Procedure data (weight loss data four years old). Monthly data is reported by same-site panels comprised of approximately 90 sites for Breast Implants, 150 physicians across 80 sites for Dermal Fillers, 300 practitioners across 150 sites for Neurotoxins, and 130 surgeons across 70 sites for Weight Loss Procedures. Since inception, Guidepoint’s Aesthetics market size,
market share and other market data have provided users with clear visibility into the market dynamics of each of the four categories.
“With the March 9th approval by the U.S. Food & Drug Administration of Sientra Inc.’s Silimed silicone gel-filled breast implant, Guidepoint’s data will look to capture this launch’s effect on overall volumes and manufacturer market shares going forward,“ observed Mr. Cosgrove. “In addition, the neurotoxin market with Botox, Dysport and Xeomin; the dermal filler market with new products emerging; and the weight loss procedural market with gastric bypass, gastric banding and sleeve gastrectomy vying for share, will all be focal points of the Aesthetics Guidepoint Tracker offering throughout the remainder of 2012.”
About Guidepoint Tracker
Guidepoint Global’s Market Tracker Solutions are longitudinal studies that equip Medical Device and Therapeutics Manufacturers and Institutional Investors with monthly volume, market share, pricing and additional commercial insight into medical device and biopharmaceutical utilization reported by representative, same-site samples.
Guidepoint Global’s Tracker data and market models are exclusively available to Clients via a secure, web-based platform.
Visit the Guidepoint Global Tracker Website for an overview of Guidepoint Global’s Tracker suite, which includes Trackers within the Aesthetics, Musculoskeletal, Cardiovascular, Ophthalmology, Oral and Therapeutics categories.
About Guidepoint Global, LLC
Guidepoint Global is a leading primary research firm that provides on-demand access to a highly-vetted global network of industry experts for qualitative research. Founded in 2003, Guidepoint covers all sectors, geographies and relevant roles. Sector expertise includes Healthcare, Technology, Media, Telecommunications, Energy, Industrials, Consumer Goods & Services, and Financial Services. Clients include some of the world’s leading institutional investors, , multinational corporations, and consulting firms.
Guidepoint offers primary research services with its network of Advisors via phone consultations, face-to-face meetings, custom surveys, and proprietary data products. These services, coupled with an industry-leading compliance platform, provide the insight required to make more informed and efficient business decisions.